New tricks for old targets: Anti-CTLA-4 antibodies re-envisioned for cancer immunotherapy
Oncotarget
.
2018 Jul 27;9(58):31171-31172.
doi: 10.18632/oncotarget.25800.
Authors
Jeremy D Waight
1
,
Dhan Chand
1
,
David A Savitsky
1
Affiliation
1
Agenus Inc., Lexington, MA, USA.
PMID:
30131845
PMCID:
PMC6101285
DOI:
10.18632/oncotarget.25800
No abstract available
Keywords:
CTLA-4; Fcγ receptors; TCR; antibody engineering; cancer immunotherapy.
Publication types
Editorial